Live Breaking News & Updates on Dose Reduction

Stay updated with breaking news from Dose reduction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lenvatinib Plus Pembrolizumab for Firstline Treatment of Advanced RCC

Elizabeth Plimack, MD, and Robert Motzer, MD, explain their preferences between TKI-IO combination therapies for patients with advanced RCC considering efficacy, side effects, and specific patient factors. ....

Elizabeth Plimack , Robert Motzer , Evolving Treatments , Advanced Renal Cell Carcinoma , Plus Pembrolizumab , Firstline Treatment , Renal Cell Carcinoma , Metastatic Renal Cell Cancer , Dose Reduction , Adjuvant Therapy , Toxicity Management , Blood Pressure , Thyroid Toxicity , Liver Toxicity , Hand Foot Syndrome ,

Available Treatment Options for Patients with Advanced RCC

Medical oncologists discuss a patient's surprising rapid decline after an initial diagnosis of clear cell RCC, emphasizing the efficacy of combination lenvatinib/pembrolizumab in similar patients. ....

Evolving Treatments , Advanced Renal Cell Carcinoma , Treatment Options , Renal Cell Carcinoma , Metastatic Renal Cell Cancer , Dose Reduction , Adjuvant Therapy , Toxicity Management , Blood Pressure , Thyroid Toxicity , Liver Toxicity , Hand Foot Syndrome ,